Biological Dynamics Selected as Winner of CONNECT’s 2018 Most Innovative New Product Award
SAN DIEGO--(BUSINESS WIRE)--Dec 7, 2018--Biological Dynamics, a company committed to improving global health outcomes by empowering global communities with accessible cancer diagnostics, today announced that its OmniVerita ™ system has been selected as the winner of CONNECT ’s Most Innovative New Product Award in the Life Science Products, Clinical Stage category. CONNECT, a premier innovation company accelerator in San Diego that creates and scales great companies in the technology and life sciences sectors, continues its 31-year tradition of celebrating innovation leaders in the local San Diego community.
OmniVerita ™ is a proprietary automated benchtop analyzer developed by Biological Dynamics. It features a novel isolation technology, Verita ™, and is designed for detection and quantification of valuable blood-based biomarkers, such as cell-free DNA, without sample pre-processing in less than one hour. The first test that will be performed using the OmniVerita will measure plasma cell-free DNA levels for the purpose of response evaluation in people undergoing treatments with anti-cancer therapies.
“Biological Dynamics is honored to be recognized as a prominent innovator in the San Diego life sciences community, especially alongside the six impressive companies that received CONNECT’s Most Innovative New Product Award in other vital technology areas,” said Raj Krishnan, CEO of Biological Dynamics. “This award is a team achievement that speaks to the dedication and passion of those who worked to make OmniVerita possible.”
The CONNECT annual awards event was held on Thursday, November 29 th, at the Hyatt Regency La Jolla at Aventine. Winners were selected in the following seven categories: Aerospace, Robotics, and Transportation; Cleantech, Sustainability, and Energy; Defense and Cybersecurity; Information Communication Technologies and Software; Life Science Diagnostics; Life Science Products (Clinical Stage) and Pharmaceuticals; Life Science Research Tools and Medical Devices.
For a complete list of winners and additional information, please visit the CONNECT’s website.
ABOUT Biological Dynamics
Biological Dynamics is an innovative diagnostic company committed to improving global health outcomes by developing low-cost, accessible cancer diagnostic solutions for labs and homes. The company’s lab-on-a-chip platform offers a novel way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The company is developing a suite of novel oncology tests for early cancer detection, treatment response, and recurrence monitoring. In addition to lab-focused products, the company is also developing a smartphone-enabled portable version of the platform, to extend molecular testing into homes.
OmniVerita ™ is for research use only, not for use in diagnostic procedures.
For more information visit us at www.biologicaldynamics.com and follow us at @BiodynSD on Twitter.
CONNECT is a premier innovation company accelerator in San Diego that creates and scales great companies in the technology and life sciences sectors. By creating an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources they need for success, CONNECT has assisted in the formation and development of more than 3,000 companies since 1985. Widely regarded as one of the world’s most successful organizations linking entrepreneurs and C-suite executives with the resources they need for the commercialization of innovative products and services; our program has been modeled in more than 50 regions around the world.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181207005038/en/
CONTACT: Kristin Deuber, 614-975-4186
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: TECHNOLOGY HARDWARE SOFTWARE SEMICONDUCTOR HEALTH BIOTECHNOLOGY CLINICAL TRIALS GENETICS ONCOLOGY
SOURCE: Biological Dynamics
Copyright Business Wire 2018.
PUB: 12/07/2018 09:00 AM/DISC: 12/07/2018 09:00 AM